These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38107797)

  • 1. Diabetes and Osteoporosis.
    Prasad TN; Arjunan D; Pal R; Bhadada SK
    Indian J Orthop; 2023 Dec; 57(Suppl 1):209-217. PubMed ID: 38107797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes mellitus and osteoporosis. Diabetes mellitus and bone and calcium metabolism].
    Watanabe R; Okazaki R
    Clin Calcium; 2012 Sep; 22(9):1307-14. PubMed ID: 22932284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Bone Mineral Density on the Incidence of Age-Related Vertebral Fragility Fracture.
    Lee J; Chang G; Kang H; Ham DW; Lee JS; Jung HS; Song KS
    J Korean Med Sci; 2020 May; 35(17):e116. PubMed ID: 32356418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk assessment in diabetes mellitus.
    Chen W; Mao M; Fang J; Xie Y; Rui Y
    Front Endocrinol (Lausanne); 2022; 13():961761. PubMed ID: 36120431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Pelvic Bone Mineral Density and With Proximal Femoral and Spine Bone Mineral Density in Post-menopausal Women.
    Mohseni M; Eisen S; Stum S; Civitelli R
    J Clin Densitom; 2022; 25(3):328-333. PubMed ID: 35177349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study.
    Chapurlat R; Bui M; Sornay-Rendu E; Zebaze R; Delmas PD; Liew D; Lespessailles E; Seeman E
    J Bone Miner Res; 2020 May; 35(5):833-844. PubMed ID: 31821619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and bone fragility- An under-recognized association.
    Farooqui KJ; Mithal A; Kerwen AK; Chandran M
    Diabetes Metab Syndr; 2021; 15(3):927-935. PubMed ID: 33932745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People with HIV infection had lower bone mineral density and increased fracture risk: a meta-analysis.
    Chang CJ; Chan YL; Pramukti I; Ko NY; Tai TW
    Arch Osteoporos; 2021 Feb; 16(1):47. PubMed ID: 33638754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
    Yamamoto M
    Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects and management of osteoporosis and fragility fractures in patients with diabetes.
    Chandran M
    Osteoporos Sarcopenia; 2017 Sep; 3(3):123-127. PubMed ID: 30775516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes.
    Vilaca T; Eastell R
    JBMR Plus; 2023 Nov; 7(11):e10838. PubMed ID: 38025034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes.
    Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Am J Med Sci; 2020 Nov; 360(5):552-559. PubMed ID: 32376002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study.
    Bliuc D; Alarkawi D; Nguyen TV; Eisman JA; Center JR
    J Bone Miner Res; 2015 Apr; 30(4):637-46. PubMed ID: 25359586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk.
    Eastell R; Vittinghoff E; Lui LY; Ewing SK; Schwartz AV; Bauer DC; Black DM; Bouxsein ML
    J Bone Miner Res; 2022 Nov; 37(11):2121-2131. PubMed ID: 36065588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD.
    Malgo F; Appelman-Dijkstra NM; Termaat MF; van der Heide HJ; Schipper IB; Rabelink TJ; Hamdy NA
    Arch Osteoporos; 2016; 11(1):12. PubMed ID: 26906974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus.
    Miyake H; Kanazawa I; Sugimoto T
    Calcif Tissue Int; 2018 Jan; 102(1):1-13. PubMed ID: 28965188
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.